Parameter | Value |
---|---|
Age, years | 50.7 ± 10.2 |
Sex | Â |
 Male | 1497 (85.1%) |
 Female | 263 (14.9%) |
α-Fetoprotein, ng/mL |  |
 ≤ 20 | 726 (41.2%) |
 20–400 | 451 (25.6%) |
 ≥ 400 | 583 (33.1%) |
HBV DNA, IU/ml | Â |
 ≤ 1000 | 801 (45.5%) |
 > 1000 | 959 (54.5%) |
White blood cells, 109/L | 5.26 ± 1.74 |
Platelet count, 109/L | 152 (23-479) |
Albumin, g/L | 41.7 ± 3.74 |
Total bilirubin, μmol/L | 13.4 (3.3–45.4) |
γ-Glutamyl transferase, IU/L | 55.0 (10–1175) |
Alkaline phosphatase, IU/L | 80.0 (17–1155) |
ALBI grade | Â |
 ≤ − 2.63 | 1270 (72.2%) |
 > 2.63 | 490 (27.8%) |
Blood loss, mL | |
 < 800 | 1650 (93.8%) |
 ≥ 800 | 110 (6.2%) |
Tumor size, cm | 5.55 ± 3.48 |
Differentiation degree | |
 I/II | 295 (16.8%) |
 III/IV | 1465 (83.2%) |
Microvascular invasion | |
 Absent | 1354 (76.9%) |
 Present | 406 (23.1%) |
AJCC stage | Â |
 T1a | 121 (6.9%) |
 T1b | 1250 (71.0%) |
 T2 | 389 (22.1%) |
BCLC stage | Â |
 0 | 121 (6.9%) |
 A | 1639 (93.1%) |
Tumor capsule | Â |
 Incomplete/absent | 1232 (70.0%) |
 Complete | 528 (30.0%) |
Cirrhosis | Â |
 Absent | 927 (52.7%) |
 Present | 833 (47.3%) |